Plicator® Outcomes

In a multi-center IDE clinical study, patients treated with the Plicator® showed sustained improvement in GERD symptoms, medication use, and distal esophageal acid exposure.1

  • 70% of patients remained off all PPI therapy at 1-year post-procedure.
  • 80% of patients demonstrated an improvement in distal esophageal acid exposure in studies conducted 6-months following plication.
  • At one-year post procedure, median GERD-HRQL scores were superior when compared to patients’ baseline on-PPI scores.

Clinical Summary


 

EGD Long-Term Follow-Up

Pre-Plication Post-Plication

3-Month Post-Plication 1 Year Post-Plication 2 Year Post-Plication